Approvals/TGA/mRESVIA respiratory syncytial virus F protein mRNA (nucleoside modified), 50 micrograms in 0.5 mL, suspension for injection, prefilled syringe.

Approved

STANDARD

mRESVIA respiratory syncytial virus F protein mRNA (nucleoside modified), 50 micrograms in 0.5 mL, suspension for injection, prefilled syringe.

Moderna Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: cc9260d9888dbae1
Company: Moderna Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: cc9260d9888dbae1
Product Name: mRESVIA respiratory syncytial virus F protein mRNA (nucleoside modified), 50 micrograms in 0.5 mL, suspension for injection, prefilled syringe.
Artg Id: 411450
Artg Name: mRESVIA respiratory syncytial virus F protein mRNA (nucleoside modified), 50 micrograms in 0.5 mL, suspension for injection, prefilled syringe.
Sponsor: Moderna Australia Pty Ltd
Company Detail Path: /organization/moderna-australia-pty-ltd
Artg Date: 2025-03-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

cc9260d9888dbae1

Type

Standard

Back to TGA Approvals